輸入代號或公司名稱後按 Enter
4911

德英

-0.10 (-0.35%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
28.406成交張數21.04本益比2.06股價淨值比6.92%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025309年增 +24.1%
毛利率202585.1%最新一期
營業利益率202549.3%最新一期
每股盈餘20252.18年增 +26.0%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計43.1%66.1%608.6%117.6%57.4%60.8%39.1%20.3%17.5%14.9%
營業毛利(毛損)56.9%33.9%-508.6%-17.6%42.6%39.2%60.9%79.7%82.5%85.1%
營業毛利(毛損)淨額56.9%33.9%-508.6%-17.6%42.6%39.2%60.9%79.7%82.5%85.1%
推銷費用7.2%13.1%173.4%24.4%15.3%30.4%14.6%13.0%13.1%17.7%
管理費用26.5%68.5%443.3%56.5%37.0%37.4%15.6%8.6%7.1%6.9%
研究發展費用109.8%138.6%704.4%64.9%45.1%51.0%22.3%13.6%14.2%11.3%
營業費用合計143.5%220.2%1125.5%145.8%97.4%118.8%52.4%35.2%34.4%35.9%
營業利益(損失)-86.6%-186.3%-1634.1%-163.4%-54.8%-79.6%8.5%44.5%48.0%49.3%
利息收入2.2%2.1%0.9%2.4%1.8%2.1%
其他收入36.3%22.1%240.8%6.6%6.5%5.0%0.1%3.0%0.3%0.0%
其他利益及損失淨額-0.7%-5.2%-0.7%0.0%-0.1%-1.6%1.6%-0.0%0.0%-0.2%
財務成本淨額0.0%0.0%0.0%
營業外收入及支出合計35.7%16.9%240.1%6.6%8.6%5.4%2.7%5.4%2.0%2.0%
稅前淨利(淨損)-51.0%-169.4%-1394.0%-156.8%-46.3%-74.2%11.2%49.9%50.1%51.2%
所得稅費用(利益)合計-8.7%21.4%-365.7%-23.6%4.4%6.8%-0.2%10.0%9.1%6.2%
繼續營業單位本期淨利(淨損)-42.3%-190.8%-1028.3%-133.1%-50.7%-80.9%11.4%39.9%41.0%45.0%
本期淨利(淨損)-42.3%-190.8%-1028.3%-133.1%-50.7%-80.9%11.4%39.9%41.0%45.0%
本期綜合損益總額-42.5%-188.8%-1028.3%-133.1%-50.7%-80.9%11.4%39.9%41.0%45.0%
基本每股盈餘-0.8%-3.4%-18.6%-2.4%-0.9%-1.5%0.2%0.7%0.7%0.7%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.7%0.7%0.7%
預期信用減損損失(利益)-195.6%0.0%
與不重分類之項目相關之所得稅-0.0%-2.0%0.0%
其他綜合損益(淨額)-0.2%2.0%0.0%
確定福利計畫之再衡量數-0.2%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。